Cerity Partners
MEDP icon

Cerity Partners’s Medpace MEDP Stock Holding History

Cerity Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.4M Buy
82,077
+1,104
+1% +$565K 0.06% 288
2025
Q4 		$45.5M Buy
80,973
+23,530
+41% +$13.4M 0.07% 253
2025
Q3 		$29.5M Buy
57,443
+21,726
+61% +$9.49M 0.05% 303
2025
Q2 		$11.2M Sell
35,717
-7,267
-17% -$2.18M 0.02% 496
2025
Q1 		$13.1M Sell
42,984
-3,695
-8% -$1.24M 0.03% 427
2024
Q4 		$15.5M Sell
46,679
-15,211
-25% -$5.16M 0.03% 376
2024
Q3 		$20.7M Buy
61,890
+9,741
+19% +$3.7M 0.05% 311
2024
Q2 		$21.5M Buy
52,149
+11,689
+29% +$4.63M 0.06% 266
2024
Q1 		$16.4M Buy
40,460
+37,997
+1,543% +$13.4M 0.04% 340
2023
Q4 		$755K Buy
2,463
+189
+8% +$51K ﹤0.01% 1097
2023
Q3 		$551K Buy
+2,274
New +$582K ﹤0.01% 947
2023
Q2 		– Sell
-1,944
Closed -$366K – 1836
2023
Q1 		$366K Sell
1,944
-227
-10% -$46.9K ﹤0.01% 1440
2022
Q4 		$461K Buy
+2,171
New +$434K ﹤0.01% 973

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cerity Partners's MEDP Position: Q1 2026 in Review

Cerity Partners increased its Medpace (MEDP) stake by 1.4% in Q1 2026, buying an estimated $565K and bringing the position to 82,077 shares worth $39.4M. The position accounts for 0.06% of the portfolio, ranked #288.

Cerity Partners first reported a position in MEDP in Q4 2022 and has held it in 13 quarters since. The position peaked at $45.5M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Cerity Partners held 82,077 shares of Medpace worth $39.4M as of Q1 2026.
  • Cerity Partners bought 1,104 Medpace shares in Q1 2026, an estimated $565K.
  • Medpace made up 0.06% of Cerity Partners's portfolio in Q1 2026, its #288 holding.
  • Cerity Partners first reported a position in Medpace in Q4 2022 and has held it in 13 quarters since.
  • Cerity Partners's Medpace position peaked at $45.5M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.